AriBioLab Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	69,581	75,894	82,084	151,036	131,749	293,364
Market Cap Growth	-11.00%	-7.54%	-45.65%	14.64%	-55.09%	-
Enterprise Value	59,363	55,705	53,558	123,500	97,133	290,192
Last Close Price	2590.00	2825.00	3060.00	5650.00	4985.00	11100.00
PS Ratio	209.72	478.48	221.45	513.51	734.04	586.73
PB Ratio	7.25	6.40	2.96	4.26	3.95	7.41
P/TBV Ratio	7.44	6.53	2.98	4.27	3.95	7.41
EV/Sales Ratio	178.92	351.19	144.49	419.89	541.18	580.38
Debt / Equity Ratio	0.62	0.75	0.35	0.12	0.71	0.53
Net Debt / Equity Ratio	-1.06	-1.25	-1.10	-0.98	-1.02	-1.03
Net Debt / EBITDA Ratio	0.78	1.07	4.24	5.87	5.64	6.97
Net Debt / FCF Ratio	0.96	1.33	3.69	6.20	6.06	7.51
Asset Turnover	0.01	0.00	0.01	0.01	0.00	0.01
Quick Ratio	1.56	1.49	4.21	48.57	2.18	2.50
Current Ratio	1.82	1.66	4.64	52.44	2.20	2.50
Return on Equity (ROE)	-89.44%	-81.07%	-32.11%	-5.09%	-18.40%	-89.44%
Return on Assets (ROA)	-25.26%	-23.16%	-10.42%	-7.56%	-6.40%	-8.35%
Return on Capital Employed (ROCE)	-118.60%	-105.00%	-20.50%	-14.50%	-18.90%	-15.00%
Earnings Yield	-22.34%	-21.14%	-12.35%	-1.16%	-5.10%	-6.28%
FCF Yield	-15.27%	-14.67%	-10.08%	-3.69%	-4.28%	-1.85%
Buyback Yield / Dilution	-0.17%	-0.13%	-1.18%	-0.26%	-13.39%	-30.03%